Latest "Biomarker discovery Driving technologies" News Stories

09:26 EDT 25th May 2015 | BioPortfolio

Here are the most relevant search results for "Biomarker discovery Driving technologies" found in our extensive news archives from over 250 global news sources.

More Information about Biomarker discovery Driving technologies on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Biomarker discovery Driving technologies for you to read. Along with our medical data and news we also list Biomarker discovery Driving technologies Clinical Trials, which are updated daily. BioPortfolio also has a large database of Biomarker discovery Driving technologies Companies for you to search.

Showing "Biomarker discovery Driving technologies" News Articles 1–25 of 6,400+


Integrating biomarkers in colorectal cancer trials in the West and China

Predictive biomarkers are invaluable for successful and cost-effective treatment of cancer, however, biomarker discovery is difficult and requires multiple independent studies to identify suitable predictors of efficacy. Clinical trials performed in ...

Medical News Today: Ovarian cancer treatment set to improve following biomarker discovery

The discovery of a biomarker that predicts the response to chemotherapy in patients with the most malignant form of ovarian cancer will help lead to better treatment options.

Biomarker Summit Europe 2015 on October 5-8, 2015 in Berlin, Germany

The summit will address the latest developments in the biomarker arena from discovery to translation to commercialization. Presentations span across multiple disciplines and cover topics such as discovery and validation strategies, the challenges of ...

Biomarker firm obtains $2.3M in funding for autism study

The Nancy Lurie Marks Family Foundation has given Stemina Biomarker Discovery $2.3 million to finance its study of autism spe -More- 

Biomarker discovery offers clearer prognosis for bowel and rectal cancer patients

For the first time, a biomarker discovered by Macquarie University and Concord Repatriation General Hospital researchers will allow clinicians to distinguish certain types of colorectal cancer patients who do relatively well after surgery from those ...

Denovo Biomarkers: Robert Little. Providing a novel biomarker solution to personalize drug development

Robert Little, the Chief Business Officer of Denovo Biomarkers reveals to Fintan Walton the use of its industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples.

Biomarker discovery sheds new light on heart attack risk of arthritis drugs

A class of drug for treating arthritis - all but shelved over fears about side effects - may be given a new lease of life, following the discovery of a possible way to identify which patients should avoid using it.

Biomarkers Summit March 18-20,2015 San Diego, CA

The Biomarker Summit 2015, to be held on March 18-20, 2015 in San Diego, CA at the Westin San Diego Hotel, is a meeting place for leaders in the field to discuss the issues and challenges scientists and researchers face in all aspects of the biomarke...

Blood test for osteoarthritis on the cards thanks to new discovery

The first blood test for osteoarthritis could soon be available following the discovery of a biomarker linked to both rheumatoid and osteoarthritis. The findings could lead to people being tested for osteoarthritis and diagnosed several years before the onset of physical symptoms. Citrullinated proteins (CPs) are the focus of the research. We already know that […] The post Blood test for ost...

A biomarker as indicator for the likelihood of developing aggressive prostate cancer

Overexpression of the protein BAZ2A, which leads to alterations in epigenetic patterns, increases the malignant properties of tumour cells, including their mobility and their ability to form metastases. The findings of a team of researchers from Heidelberg, Zurich and Hamburg may have led to the discovery of an urgently needed prognostic biomarker that would make it possible to differentiate aggre...

A novel biomarker for mutant p53 could help pathologists assessing tumors during surgery

(Cold Spring Harbor Laboratory) Researchers at Cold Spring Harbor Laboratory today report the discovery of a novel cellular biomarker that could make it comparatively easy for cancer surgeons to determine if a patient has a potentially lethal mutatio...

Next generation biomarker detects tumour cells and delivers anti-cancer drugs

Nanyang Technological University (NTU) has invented a unique biomarker with two exceptional functions.

Pragmatic issues in biomarker evaluation for targeted therapies in cancer

Biomarkers that predict a patient's responsiveness to anticancer therapies are of increasing importance during drug development and in clinical trials, as well as in the clinic. In this Review, the major challenges to biomarker development and standa...

Transgenomic – genetic biomarker identification

Transgenomic is a biotech company identifying genetic biomarker using proprietary methods and assays. Transgenomic – genetic biomarker identification Transgenomic is advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies. This biotech company is a global … Continue reading → Cet article Transgenomic – g...

Cancer Biomarker and Drug Delivery System in One

Next generation biomarker detects tumor cells and delivers anti-cancer drugsRead more about Cancer Biomarker and Drug Delivery System in OneComments

Epistem announces collaboration with Sanofi Aventis

Epistem plc, the UK biotechnology and personalised medicine company today announced a collaboration with sanofi-aventis U.S. Inc. relating to the use of Epistem's proprietary biomarker gene expression profiling and immunohistochemistry technologies. ... Rising Prevalence of Cancer Driving the Global and US Cancer Biomarker Market to 2018 has announced the addition of the “Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)” report to their offering. Albany, NY (PRWEB) December 09, 2014 This report is a study of the global oncogenic or canc...

Alexion, Blueprint to develop, market rare genetic disease treatments

Blueprint Medicines is partnering with Alexion to use its kinase-focused drug-discovery technology to research, develop and m -More- Biomarkers Summit 2015 Register for the Biomarkers Summit 2015 on March 18-20, 2015 in San Diego, CA. Meet ...

Aptagen – aptamer-beacon

Aptagen is a biotech company proposing aptamer products and services as reagents, diagnostic and biomarker discovery tools. Aptamers are used in drug discovery, targeted delivery for therapeutics or bioindustrial applications. Aptagen – aptamer-beacon Aptamers (synthetic antibodies) are ligands of RNA, … Continue reading → Cet article Aptagen – aptamer-beacon est apparu en ...

Amarantus and Anavex in AD biomarker collaboration

Amarantus BioScience Holdings (OTCQB:AMBS) and Anavex Life Sciences (OTCQX:AVXL) have signed a biomarker services agreement in which Amarantus will evaluate the pharmacodynamic effect of ANAVEX 2-73 and ANAVEX PLUS on the expression of the biomarker CD69 in specific sub-populations of peripheral blood lymphocytes, using Amarantus’ proprietary Alzheimer’s blood diagnostic LymPro Test. T...

AYOXXA and SERI to collaborate on protein biomarker detection

AYOXXA and SERI will work together on validating the company’s multiplexing technology platform for protein biomarker detection, as part of an expanded collaboration for developing ophthalmic diagnostic tools... The post AYOXXA and SERI to collabor...

Retrospective Sample Collection for Biomarker Discovery, New Webinar Hosted by Xtalks

TORONTO, ON--(Marketwired - March 17, 2015) - Join speakers from Almac Diagnostics, including Dr. Peter Kerr, Head of Project Management & Product Development, and Kinga Wojciechowska, Project Manager for Ethics/Tissue Collection, as they discuss sample access and profiling for biomarker discovery to help rescue or reposition drugs. The complimentary 60-minute broadcast takes place on Wednesda...

Traffic stops and DUI arrests linked most closely to lower drinking and driving

From 1982 to 1997, American states got tough on impaired driving. Policies favored adopting lower blood alcohol concentration (BAC) limits for driving, administrative license revocation (ALR), and increased sanctions for those convicted of driving un...

SGS adds to biomarker analysis service

SGS Life Science Services, a clinical and bioanalytical contract group has invested in additional modules for its COBAS 6000 analysis system, to increase its biomarker analytical capabilities.

Wayne State University study reveals mature motorists worse at texting and driving

(Wayne State University - Office of the Vice President for Research) A Wayne State University interdisciplinary research team in the Eugene Applebaum College of Pharmacy and Health Sciences has made a surprising discovery: Older, more mature motorist...

Search BioPortfolio:

News Quicklinks